Concepedia

Molecular epidemiologic features of inflammatory breast cancer: a comparison between Egyptian and US patients

An-Chi Lo, Celina G. Kleer, Mousumi Banerjee, Sherif Omar, Hussein Khaled, Ahmed Hablas, Julie A. Douglas, Sharon Hensley Alford, Sofía D. Merajver, Amr S. Soliman

Breast Cancer Research and Treatment · 2007 · 24 citations · 27 references

DOI

Concepts

References

27

LYVE-1, a New Homologue of the CD44 Glycoprotein, Is a Lymph-specific Receptor for Hyaluronan

Suneale Banerji, Jian Ni, Shuxia Wang et al. · The Journal of Cell Biology · 1999 · 1.6K citations · Full text

Trends in Inflammatory Breast Carcinoma Incidence and Survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer Institute

Kenneth W. Hance, William F. Anderson, Susan S. Devesa et al. · JNCI Journal of the National Cancer Institute · 2005 · 695 citations · Full text

RhoC GTPase, a novel transforming oncogene for human mammary epithelial cells that partially recapitulates the inflammatory breast cancer phenotype.

Zhi-Fen Wu, XiaoTan Qiao, Liwen Bao et al. · PubMed · 2000 · 319 citations

, , +14

A novel putative low-affinity insulin-like growth factor-binding protein, LIBC (lost in inflammatory breast cancer), and RhoC GTPase correlate with the inflammatory breast cancer phenotype.

S. J. Davies, Zhi-Fen Wu, Y Wang et al. · PubMed · 1999 · 254 citations

, , +15

Inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program of the National Cancer Institute, 1975-1992.

Shine Chang, Sheryl L. Parker, Tuan Pham et al. · PubMed · 1998 · 233 citations